Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Presenter
Browse by Presenter
Browse by Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yeh, Jen Jen
University of North Carolina at Chapel Hill
Discussions and Q&A
Jen Jen Yeh
The Future of Precision Medicine in the Management of Pancreatic Cancer
Jen Jen Yeh
Yonkus, Jennifer
Mayo Clinic
A2: Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-volume Peritoneal Metastases: A Phase I Clinical Trial
Jennifer Yonkus
A2: Q&A
Jennifer Yonkus
Yoon, Sam
Columbia University Irving Medical Center
82: Q&A
Sam Yoon
82: Tumor-derived Organoids from Patients with Locally Advanced Gastric Adenocarcinoma Can Predict Resistance to Neoadjuvant Chemotherapy
Sam Yoon
Yopp, Adam
UT Southwestern Medical Center
How to Become an NIH Funded Investigator in a “team Science” Environment (When You Don't Want to Be the PI of a Lab)
Adam Yopp
Paradigm Shift in the Treatment Options of Hepatocellular Carcinoma
Adam Yopp
SSO 2022 Pre-meeting Robotics Surgery
Adam Yopp
Young, Geoffrey
Miami Cancer Institute
Papillary Thyroid Cancer
Geoffrey Young
Transoral Robotic Surgery
Geoffrey Young
Young, Stephanie
Saint John's Cancer Institute
AP6 Cytoreductive Surgery for Metastatic Colorectal Cancer in the Era of Modern Systemic Therapy – a Shifting Paradigm!
Stephanie Young
You, Y. Nancy
University of Texas MD Anderson Cancer Center
Total Neoadjuvant Therapy Should Be Used Routinely and Considered the New Standard for Locally Advanced (T3/4 or N+) Rectal Cancer (Pro)
Y. Nancy You
Yu, Jingjing
University of California, Irvine Medical Center
A28: Exosome Liquid Biopsy in Colon Cancer Utilizing RNA Biomarkers: An Initial Analysis
Jingjing Yu
A28: Q&A
Jingjing Yu
Back to Top
